Abstract

Regulatory CD19+CD24hiCD27+ B cells were proved to be numerically decreased and functionally impaired in the peripheral blood (PB) from rheumatoid arthritis (RA), with the potential of converting into osteoclast-priming cells. However, the distribution and function of CD19+CD24hiCD27+ B cells in RA synovial fluid (SF) were unclear. In this study, we investigated whether RA SF CD19+CD24hiCD27+ B cells were increased and associated with bone destruction. We found that the proportion of RA SF CD19+CD24hiCD27+ B cells was increased significantly, and was positively correlated with swollen joint counts, tender joint counts and disease activity. CXCL12, CXCL13, CCL19 contributed to the recruitment of CD19+CD24hiCD27+ B cells in RA SF. Notably, CD19+CD24hiCD27+ B cells in the SF from RA expressed significantly more RANKL compared to OA and that in the PB from RA. Critically, RA CD19+CD24hiCD27+ B cells promoted osteoclast (OC) differentiation in vitro, and the number of OCs was higher in cultures with RA SF CD19+CD24hiCD27+ B cells than in those derived from RA PB. Collectively, these findings revealed the accumulation of CD19+CD24hiCD27+ B cells in SF and their likely contribution to joint destruction in RA. Modulating the status of CD19+CD24hiCD27+ B cells might provide novel therapeutic strategies for RA.

Highlights

  • Regulatory ­CD19+CD24hiCD27+ B cells were proved to be numerically decreased and functionally impaired in the peripheral blood (PB) from rheumatoid arthritis (RA), with the potential of converting into osteoclast-priming cells

  • We have shown that C­ D19+CD24hiCD27+ B cell numbers were higher in RA synovial fluid (SF) than that in OA SF and RA PB

  • The percentage of RA SF ­CD19+CD24hiCD27+ B cells was positively correlated with swollen joint counts, tender joint counts, disease activity score in 28 joints (DAS28) and Sharp/van der Heijde score (SHS)

Read more

Summary

Introduction

Regulatory ­CD19+CD24hiCD27+ B cells were proved to be numerically decreased and functionally impaired in the peripheral blood (PB) from rheumatoid arthritis (RA), with the potential of converting into osteoclast-priming cells. RA ­CD19+CD24hiCD27+ B cells promoted osteoclast (OC) differentiation in vitro, and the number of OCs was higher in cultures with RA SF ­CD19+CD24hiCD27+ B cells than in those derived from RA PB These findings revealed the accumulation of ­CD19+CD24hiCD27+ B cells in SF and their likely contribution to joint destruction in RA. Studies of RANKL production in RA indicated that synovial fibroblasts and activated T cells produce excess RANKL and may contribute to osteoclastic bone r­ esorption[6,7,8]. Our previous study has shown that PB C­ D19+CD24hiCD27+ B cells have the potential of converting into RANKLproducing cells in RA ­patients[18] These findings highlight the important role of B cells in modulating bone. Characteristics of ­CD19+CD24hiCD27+ B cells in RA patient synovial fluids remain unclear

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call